This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Insulin Pens Market

Market Insights on Insulin Pens covering sales outlook, demand forecast & up-to-date key trends

Insulin Pens Market by Product Type (Reusable Insulin Pen, Disposable Insulin Pens, Smart Insulin Pen Caps, Insulin Pump), Indication (Type 1, Type 2), Distribution Channel & Region - Forecast to 2021-2031

Insulin Pen Market Snapshot

[200 Pages Report] The incidence of diabetes is rising as poor lifestyle choices remain prevalent across the world. Insulin pens are widey adopted solution for administering treatment to diabetes patients. Considering this, Future Market Insights forecasts sales of insulin pen to total US$ 30,407 Mn in 2021.

Rising at a CAGR of 4.4% between 2021 and 2031, insulin pen market value is forecast to reach US$ 46,906.4 Mn by 2031. Insulin pens for type 2 diabetes patients will contribute to over 70% of insulin pen sales through 2031. Demand in this category is expected to rise at a CAGR of above 4%.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Insulin Pen Market Study

  • Insulin Pen Market estimates and forecast 2016-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Conditions
  • COVID-19 Impact on Insulin Pen Market and How to Navigate
  • Recommendation on Key Winning Strategies

2016-2020 Insulin Pen Market Outlook Compared to 2021-2031 Forecast

According to Future Market Insights (FMI), the sales of insulin pens have grown at a 3.9% CAGR between 2016 and 2020. Insulin pens are designed for the people who suffered from Type 1 or Type 2 diabetes.

For the treatment of Type 1 and Type 2 diabetes various products are used like reusable insulin pen, disposable insulin pens, smart insulin pen caps, and insulin pumps. These pens are gaining popularity because they ensure easy administration of medication, while maintaining higher accuracy of dosages.

Insulin Pens Market Download Report Brochure

With an aim of making patient care mor convenient, some of the leading companies are introducing advanced versions of insulin pens. For instance, in February 2020, NovoNordisk expanded its production capacity for manufacturing a wide range of facilities related to the diabetes. In October 2018, NovoNordisk announced their plan of launching its two connected insulin pen – NovoPen 6 and NovoPen Echo Plus.

Significant capital investment is required in the development stages of advanced insulin pens. With the rise in the number of new entrants, the overall research and development (R&D) expenses are projected to rise, along with collaborations and licensing agreements with research and academic institutes.

The demand for insulin pens also will rise on account of increasing healthcare spending in developed countries. Emerging markets, especially large markets such as India and China, have significant untapped potential. This will present attractive opportunities for the market to capitalize on. Future Market Insights expects the global insulin pen market to rise at 4.4% CAGR between 2021 and 2031.

How is the High Prevalence of Diabetes Affecting the Insulin Pen Market?

When the human body is not able to produce or utilize enough insulin it leads to the situation of diabetes. It can result in various health issues including cardiovascular diseases. According to the World Health Organization (WHO), approximately 1.2 million deaths were caused due to diabetes in 2019 worldwide.

As a result, the growing number of diabetes cases in the world will create demand for the better treatment options to manage insulin levels, thus driving the growth of overall global insulin pen market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How will Technological Advancements Affect Insulin Pen Sales Growth?

In the case of insulin pens, advancements in technology and use of advanced designs are preferred over conventional methods of administering insulin such as syringes and needles. The use of smart phone and internet technologies are being integrated with insulin pen offerings. It makes the process faster and accurate.

Emerging market players are engrossed in developing advanced devices including smart pens and smart insulin caps that can be connected through mobile technologies. E- Commerce is gaining popularity in the last few years owing to the prominence of the internet.

Also, the COVID-19 pandemic has created a scenario in which e-commerce is preferred due to the social distancing rules. Thus, online availability of diabetes management systems for provides great opportunities for market growth.

What are the Factors Restraining the Demand for Insulin Pens?

The high cost of insulin pens is restricting the adoption of these products and generating hesitancy to replace conventional products. Insulin pens cost approximately USD$ 500 which is high as compared to other methods.

Also, a lack of understanding regarding associated technology among diabetes patients is also restricting the insulin pen market. The devices are fairly complex to produce, which creates difficulties for users. Such obstacles would have a direct impact on the overall user convenience of insulin delivery pens, thus limiting revenue generation.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Impact of the COVID-19 Crisis on the Insulin Pen Market?

The COVID-19 pandemic moderately impacted the growth of the insulin pen market. This was mainly attributed to the rising number of diabetes patients in the world during the period. This is especially important as diabetics are vulnerable to morbidity and mortality from the virus.

Many people lost their jobs due to pandemic, which has led in difficultty for the patients to adopt expensive diabetes management products like insulin pens.

Also, on the other hand, pandemic has enhanced the demand of online sales, with many users prefering home delivery of the products like insulin pens and other diabetes care products to avoid exposure to the virus while following social distancing guidelines.

Insulin Pen Market - Country-wise Insights

What Supports Increasing Insulin Pen Sales in the U.S.?

The U.S. holds over 93% share of the insulin pen market in North America. In the U.S., the market is driven by research collaborations and license agreements for healthcare products. Rising technological advancements gives opportunities to manufacturers to launch innovative products to targeted diabetes management.

Moreover, key players are focusing on strategies such as new product launches in the country for diabetes management solutions. In January 2021, Insulet Corporation introduced OmipodDASH Insulin Management Systems.

What are the Factors Driving Revenue Generation in the U.K.?

The U.K. market accounts for over 18% of the Europe market through the assessment period ending in 2031. Rising prevalence of diabetes patients and technological advancement in the healthcare sector are key factors speeding growth in the U.K. market for insulin pen production and sales.

What is the Key Factor Enabling Growth in Germany?

Germany’s market accounts for over 25% market share of Europe throughout the forecast period. The key players of the country are focused towards expanding their presence in the country through the launches of innovative products into the market.

For instance, in August 2016, Emperra GmbH E-Health Technologies launched its Bluetooth insulin pen with automatic wireless data transfer expanding its ESYSTA product system in Germany.

What are the Favorable Policies Driving the Japan Market?

In 2021, the Japan market is estimated to account for more than 38% of the sales registered in East Asia. Increasing healthcare spending has improved the healthcare infrastructure in the country, while boosting the demand for innovative medical products in countries like Japan.

In 2020, Japan spent ~18% of its GDP on healthcare. This benefits key players of the country to expand and launch new products in the healthcare sector.

What is the Scope of Growth for Insulin Pen Manufacturers in China?

The market for insulin pens in China is exhibiting a 4.7% CAGR, and is expected to account for more than 48% of the East Asia market throughout the projection period. Large emerging markets, especially in China have a great opportunity in expansion. This can be broadly attributed to continuous improvements towards the concept of treatments and the availability of innovative products.

Insulin Pen Market - Category-wise Insights

How are Reusable Insulin Pens Contributing to Revenue Generation?

Reusable insulin pens are displaying a high growth potential in the coming years. It is projected to grow at CAGR of 4.1% in the near future with revenue totalling US$ 16,810.0 Mn for 2020.

Insulin pens are widely used by the diabetes patients instead of conventional syringe and needle owing to ease of administration superior accuracy.

What is the Market Share of Type 2 Diabetes?

Type 2 diabetes solutions will continue to dominate the market during the forecast period and are expected to hold around 70% of the market share through the end of 2031. Higher number of type 2 cases and investments into associated research drives growth.

What is the Scope of Growth for Online Sales?

Despite hospital pharmacies currently leading the market, online sale have displayed significant scope for growth in the insulin pen market with a 5.7% CAGR in the forecast period.

This will be primarily attributed to higher acceptance of online sales channels which provides discounts and offers as a low-cost alternatives in addition to home delivery services.

Insulin Pen Market - Competitive Landscape

Manufacturers in the insulin pen market are primarily aiming to carry out strategic acquisitions, collaborations, and product launches in the upcoming decade.

  • For Instance, Sanofi introduced its reusable insulin delivery pen – Lantus ClikSTAR in Canada in October 2020.
  • In February 2021, Eli Lily & Co. collaborated with Welldoc to link Lily’s upcoming connected insulin device and therapies.
  • In June 2021, Bigfoot Biomedical announced its acquisition of intellectual property assets of Common Sensing to strengthen its insulin delivery portfolio.

Insulin Pen Market - Scope of the Report

Attribute

Details

Insulin Pen Market  Forecast Period

2021-2031

Historical Data Available for

2016-2020

Insulin Pen Market Analysis

USD Million for Value/ Units in Million for Volume

Insulin Pen Market Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Insulin Pen Market -  Key Segments Covered

Product Type, Indication, Distribution Channel, and Region

Insulin Pen Market  - Key Companies Profiled

  • NovoNordisk A/S
  • Sanofi
  • Eli Lilly
  • Diamesco Co., Ltd.
  • BigFoot Biomedical, Inc
  • Medtronic plc
  • Emperra GmbH E-Health Technologies
  • YpsoMed AG
  • DUKADA Aps

 

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Insulin Pens Market by Category

By Product Type:

  • Reusable Insulin Pen
    • Refillable Pens
    • Bluetooth Connected Smart Insulin Pen
    • USB Connected Smart Insulin Pen
    • Cartridge
  • Disposable Insulin Pens
  • Smart Insulin Pens Caps
  • Insulin Pump

By Indication:

  • Type 1
  • Type 2

Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinic/Center

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global insulin pen market is estimated to be worth over US$ 30 Bn by 2021.

The global insulin pen market is forecasted to surpass US$ 46.9 Bn by the end of 2031.

Between 2016 and 2020, the insulin pen market grew at a 3.9% CAGR.

Novonordisk A/S, Sanofi, Medtronic Plc, Eli Lilly, and Diamesco Co. Ltd. are leading companies, accounting for 59.9% of the global market.

The U.S., Canada,Germany, the U.K., and China are the top countries reflecting consistently high demand.

North America is a leading market accounting for 62.8% of the global value share in 2021.

The Europe market for insulin pens is projected to grow at a 3.7% CAGR through the assessment period.

The U.S., Denmark, and France are leading producers of insulin pens.

NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, YpsoMed AG, and DUKADA Aps are the top exporters of insulin pens.

China and Japan account for 4.4% and 3.4% of the global insulin pens market in 2021.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. GDP Growth Outlook

        4.1.2. Global Healthcare Industry Outlook

        4.1.3. Increasing Per Capita Healthcare Spending

        4.1.4. Income Per Capita Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. GDP Growth

        4.2.2. Healthcare Spending

        4.2.3. Prevalence of Chronic Diseases

        4.2.4. COVID Pandemic

        4.2.5. Product Adoption Rate

        4.2.6. Regulatory Framework

        4.2.7. Advancements in Technologies

        4.2.8. Cost of Products

        4.2.9. Key Market Player Revenue Analysis

        4.2.10. Recent Key Players Activities

        4.2.11. Alternative Products

        4.2.12. Other Macroeconomic factors impacting insulin pen market

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Market Context

    5.1. Technology Roadmap – Evolution of Safety Devices & Insulin Delivery

    5.2. Key Regulatory Scenario

    5.3. Value Chain Analysis

    5.4. Production Analysis

    5.5. Disease Epidemiology

    5.6. Key Products USP Analysis

6. COVID19 Crisis Analysis

    6.1. Current Economic Projection as compared to 2008 financial analysis

    6.2. COVID19 and Impact Analysis

        6.2.1. Revenue by Product

        6.2.2. Revenue by Indication

        6.2.3. Revenue by Distribution Channel

        6.2.4. Revenue by Country

    6.3. 2020 Market Scenario

7. Global Insulin Pen Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (Units) Analysis, 2016-2020

    7.2. Current and Future Market Volume (Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Insulin Pen Market - Pricing Analysis

    8.1. Country Pricing Analysis by Product Type

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Latin America and Middle East Average Pricing Analysis Benchmark

9. Global Insulin Pen Market Value Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031, by Product Type 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Product Type, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product Type, 2021-2031

        10.3.1. Reusable Insulin Pen

            10.3.1.1. Refillable Pens

            10.3.1.2. Bluetooth Connected Smart Insulin Pen

            10.3.1.3. USB Connected Smart Insulin Pen

            10.3.1.4. Cartridge 

        10.3.2. Disposable Insulin Pens

        10.3.3. Smart Insulin Pen Caps

        10.3.4. Insulin Pump

    10.4. Market Attractiveness Analysis by Product Type

11. Global Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031, by Indication 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis by Indication, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2021-2031

        11.3.1. Type 1

        11.3.2. Type 2

    11.4. Market Attractiveness Analysis by Indication

12. Global Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021-2031

        12.3.1. Hospital Pharmacy

        12.3.2. Retail Pharmacy

        12.3.3. Online Sales

        12.3.4. Diabetes Clinic/Center 

    12.4. Market Attractiveness Analysis by Distribution Channel

13. Global Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        14.3.1.  By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product Type

        14.3.3. By Indication

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product Type

        15.3.3. By Indication

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        16.3.1.  By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. Rest of Europe

        16.3.2. By Product Type

        16.3.3. By Indication

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product Type

        17.3.3. By Indication

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        18.3.1.  By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

            18.3.1.4. Rest of East Asia

        18.3.2. By Product Type

        18.3.3. By Indication

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        19.3.1.  By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product Type

        19.3.3. By Indication

        19.3.4. By Distribution Channel

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. South Africa

            20.3.1.3. Rest of Middle East and Africa

        20.3.2. By Product Type

        20.3.3. By Indication

        20.3.4. By Distribution Channel

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Insulin Pen Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Insulin Pen Market Analysis

        21.2.1. By Product Type

        21.2.2. By Indication

        21.2.3. By Distribution Channel

    21.3. Canada Insulin Pen Market Analysis

        21.3.1. By Product Type

        21.3.2. By Indication

        21.3.3. By Distribution Channel

    21.4. Mexico Insulin Pen Market Analysis

        21.4.1. By Product Type

        21.4.2. By Indication

        21.4.3. By Distribution Channel

    21.5. Brazil Insulin Pen Market Analysis

        21.5.1. By Product Type 

        21.5.2. By Indication

        21.5.3. By Distribution Channel

    21.6. U.K. Insulin Pen Market Analysis

        21.6.1. By Product Type

        21.6.2. By Indication

        21.6.3. By Distribution Channel

    21.7. Germany Insulin Pen Market Analysis

        21.7.1. By Product Type

        21.7.2. By Indication

        21.7.3. By Distribution Channel

    21.8. France Insulin Pen Market Analysis

        21.8.1. By Product Type

        21.8.2. By Indication

        21.8.3. By Distribution Channel

    21.9. Italy Insulin Pen Market Analysis

        21.9.1. By Product Type

        21.9.2. By Indication

        21.9.3. By Distribution Channel

    21.10. Spain Insulin Pen Market Analysis

        21.10.1. By Product Type

        21.10.2. By Indication

        21.10.3. By Distribution Channel

    21.11. BENELUX Insulin Pen Market Analysis

        21.11.1. By Product Type

        21.11.2. By Indication

        21.11.3. By Distribution Channel

    21.12. Russia Insulin Pen Market Analysis

        21.12.1. By Product Type

        21.12.2. By Indication

        21.12.3. By Distribution Channel

    21.13. China Insulin Pen Market Analysis

        21.13.1. By Product Type

        21.13.2. By Indication

        21.13.3. By Distribution Channel

    21.14. Japan Insulin Pen Market Analysis

        21.14.1. By Product Type

        21.14.2. By Indication

        21.14.3. By Distribution Channel

    21.15. South Korea Insulin Pen Market Analysis

        21.15.1. By Product Type

        21.15.2. By Indication

        21.15.3. By Distribution Channel

    21.16. India Insulin Pen Market Analysis

        21.16.1. By Product Type

        21.16.2. By Indication

        21.16.3. By Distribution Channel

    21.17. ASEAN Insulin Pen Market Analysis

        21.17.1. By Product Type

        21.17.2. By Indication

        21.17.3. By Distribution Channel

    21.18. Australia Insulin Pen Market Analysis

        21.18.1. By Product Type

        21.18.2. By Indication

        21.18.3. By Distribution Channel

    21.19. New Zealand Insulin Pen Market Analysis

        21.19.1. By Product Type

        21.19.2. By Indication

        21.19.3. By Distribution Channel

    21.20. GCC Countries Insulin Pen Market Analysis

        21.20.1. By Product Type

        21.20.2. By Indication

        21.20.3. By Distribution Channel

    21.21. Turkey Insulin Pen Market Analysis

        21.21.1. By Product Type

        21.21.2. By Indication

        21.21.3. By Distribution Channel

    21.22. South Africa Insulin Pen Market Analysis

        21.22.1. By Product Type

        21.22.2. By Indication

        21.22.3. By Distribution Channel

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

        22.4.1. By Regional Foot Print of Players

        22.4.2. Product Foot Print by Players

        22.4.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive 

        23.3.1. NovoNordisk A/S

        23.3.2. Overview

            23.3.2.1. Product Portfolio

            23.3.2.2. Analyst Commentary 

            23.3.2.3. Key Financials

            23.3.2.4. Recent Developments

            23.3.2.5. Sales Footprint

            23.3.2.6. Strategy Overview

                23.3.2.6.1. Marketing Strategy

                23.3.2.6.2. Product Strategy

                23.3.2.6.3. Channel Strategy

        23.3.3. Sanofi

            23.3.3.1. Product Portfolio

            23.3.3.2. Analyst Commentary 

            23.3.3.3. Key Financials

            23.3.3.4. Recent Developments

            23.3.3.5. Sales Footprint

            23.3.3.6. Strategy Overview

                23.3.3.6.1. Marketing Strategy

                23.3.3.6.2. Product Strategy

                23.3.3.6.3. Channel Strategy

        23.3.4. Eli Lilly

            23.3.4.1. Product Portfolio

            23.3.4.2. Analyst Commentary 

            23.3.4.3. Key Financials

            23.3.4.4. Recent Developments

            23.3.4.5. Sales Footprint

            23.3.4.6. Strategy Overview

                23.3.4.6.1. Marketing Strategy

                23.3.4.6.2. Product Strategy

                23.3.4.6.3. Channel Strategy

        23.3.5. Diamesco Co., Ltd.

            23.3.5.1. Product Portfolio

            23.3.5.2. Analyst Commentary 

            23.3.5.3. Key Financials

            23.3.5.4. Recent Developments

            23.3.5.5. Sales Footprint

            23.3.5.6. Strategy Overview

                23.3.5.6.1. Marketing Strategy

                23.3.5.6.2. Product Strategy

                23.3.5.6.3. Channel Strategy

        23.3.6. Emperra GmbH E-Health Technologies

            23.3.6.1. Product Portfolio

            23.3.6.2. Analyst Commentary 

            23.3.6.3. Key Financials

            23.3.6.4. Recent Developments

            23.3.6.5. Sales Footprint

            23.3.6.6. Strategy Overview

                23.3.6.6.1. Marketing Strategy

                23.3.6.6.2. Product Strategy

                23.3.6.6.3. Channel Strategy

        23.3.7. BigFoot Biomedical, Inc.

            23.3.7.1. Product Portfolio

            23.3.7.2. Analyst Commentary 

            23.3.7.3. Key Financials

            23.3.7.4. Recent Developments

            23.3.7.5. Sales Footprint

            23.3.7.6. Strategy Overview

                23.3.7.6.1. Marketing Strategy

                23.3.7.6.2. Product Strategy

                23.3.7.6.3. Channel Strategy

        23.3.8. Medtronic plc

            23.3.8.1. Product Portfolio

            23.3.8.2. Analyst Commentary 

            23.3.8.3. Key Financials

            23.3.8.4. Recent Developments

            23.3.8.5. Sales Footprint

            23.3.8.6. Strategy Overview

                23.3.8.6.1. Marketing Strategy

                23.3.8.6.2. Product Strategy

                23.3.8.6.3. Channel Strategy

        23.3.9. YpsoMed AG

            23.3.9.1. Product Portfolio

            23.3.9.2. Analyst Commentary 

            23.3.9.3. Key Financials

            23.3.9.4. Recent Developments

            23.3.9.5. Sales Footprint

            23.3.9.6. Strategy Overview

                23.3.9.6.1. Marketing Strategy

                23.3.9.6.2. Product Strategy

                23.3.9.6.3. Channel Strategy

        23.3.10. DUKADA Aps

            23.3.10.1. Product Portfolio

            23.3.10.2. Analyst Commentary 

            23.3.10.3. Key Financials

            23.3.10.4. Recent Developments

            23.3.10.5. Sales Footprint

            23.3.10.6. Strategy Overview

                23.3.10.6.1. Marketing Strategy

                23.3.10.6.2. Product Strategy

                23.3.10.6.3. Channel Strategy

        23.3.11. Insulet Corporation

            23.3.11.1. Product Portfolio

            23.3.11.2. Analyst Commentary 

            23.3.11.3. Key Financials

            23.3.11.4. Recent Developments

            23.3.11.5. Sales Footprint

            23.3.11.6. Strategy Overview

                23.3.11.6.1. Marketing Strategy

                23.3.11.6.2. Product Strategy

                23.3.11.6.3. Channel Strategy

        23.3.12. Tandem Diabetes Care, Inc.

            23.3.12.1. Product Portfolio

            23.3.12.2. Analyst Commentary 

            23.3.12.3. Key Financials

            23.3.12.4. Recent Developments

            23.3.12.5. Sales Footprint

            23.3.12.6. Strategy Overview

                23.3.12.6.1. Marketing Strategy

                23.3.12.6.2. Product Strategy

                23.3.12.6.3. Channel Strategy

        23.3.13. Abbott Laboratories

            23.3.13.1. Product Portfolio

            23.3.13.2. Analyst Commentary 

            23.3.13.3. Key Financials

            23.3.13.4. Recent Developments

            23.3.13.5. Sales Footprint

            23.3.13.6. Strategy Overview

                23.3.13.6.1. Marketing Strategy

                23.3.13.6.2. Product Strategy

                23.3.13.6.3. Channel Strategy

        23.3.14. BIOCORP

            23.3.14.1. Product Portfolio

            23.3.14.2. Analyst Commentary 

            23.3.14.3. Key Financials

            23.3.14.4. Recent Developments

            23.3.14.5. Sales Footprint

            23.3.14.6. Strategy Overview

                23.3.14.6.1. Marketing Strategy

                23.3.14.6.2. Product Strategy

                23.3.14.6.3. Channel Strategy

        23.3.15. Insulcloud S.L.

            23.3.15.1. Product Portfolio

            23.3.15.2. Analyst Commentary 

            23.3.15.3. Key Financials

            23.3.15.4. Recent Developments

            23.3.15.5. Sales Footprint

            23.3.15.6. Strategy Overview

                23.3.15.6.1. Marketing Strategy

                23.3.15.6.2. Product Strategy

                23.3.15.6.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 02: Global Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 03: Global Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 04: Global Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 05: Global Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 06: Global Insulin Pen Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 07: Global Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 08: Global Insulin Pen Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 09: North America Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 10: North America Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 11: North America Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 12: North America Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 13: North America Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 14: North America Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 15: North America Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 16: Latin America Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 17: Latin America Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 18: Latin America Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 19: Latin America Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 20: Latin America Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 21: Latin America Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 22: Latin America Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 23: Latin America Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 24: Europe Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 25: Europe Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 26: Europe Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 27: Europe Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 28: Europe Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 29: Europe Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 30: Europe Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 31: Europe Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 32: South Asia Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 33: South Asia Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 34: South Asia Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 35: South Asia Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 36: South Asia Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 37: South Asia Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 38: South Asia Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 39: South Asia Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 40: East Asia Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 41: East Asia Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 42: South Asia Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 43: East Asia Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 44: East Asia Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 45: East Asia Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 46: East Asia Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 47: East Asia Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 48: Oceania Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 49: Oceania Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 50: Oceania Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 51: Oceania Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 52: Oceania Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 53: Oceania Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 54: Oceania Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 55: Oceania Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 56: MEA Insulin Delivery Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 57: MEA Insulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 58: MEAInsulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 59: MEAInsulin Pen Market Volume (Million Units) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 60: MEA Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type

Table 61: MEA Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031,By Indication

Table 62: MEA Insulin Pen Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 63: MEA Insulin Pen Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Insulin Pen Market Revenue Share by Product Type, 2021E & 2031F

Figure 02: Global Insulin Market Revenue Share by Indication,2021E & 2031F

Figure 03: Global Insulin Market Revenue Share by Distribution Channel, 2021E & 2031F

Figure 04: Global Insulin Pen Market Historical Market Volume (Million Units Mn) Analysis, 2016-2020

Figure 05: Global Insulin Pen Market Volume (Million Units), 2021-2031 & Y-o-Y Growth Trend Analysis

Figure 06: Global Insulin Pen Market Historical Market Value (US$ Mn) Analysis, 2016-2020

Figure 07: Global Insulin Pen Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis

Figure 08: Global Insulin Pen Market Absolute $ Opportunity, 2021–2031

Figure 09: Global Insulin Pen Market Share Analysis (%) By Product Type, 2021 & 2031

Figure 10: Global Insulin Pen Market Y-o-Y Growth (%) By Product Type, 2021-2031

Figure 11: Global Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 12: Global Insulin Pen Market Share Analysis (%) By Indication, 2021 & 2031

Figure 13: Global Insulin Pen Market Y-o-Y Growth (%) By Indication, 2021-2031

Figure 14: Global Insulin Pen Market Attractiveness Analysis, By Indication

Figure 15: Global Insulin Pen Market Share Analysis (%) By Distribution Channel,2021 & 2031

Figure 16: Global Insulin Pen Market Y-o-Y Growth (%) By Distribution Channel,2021-2031

Figure 17: Global Insulin Pen Market Attractiveness Analysis, By Distribution Channel

Figure 18: Global Insulin Pen Market Share Analysis (%) By Region, 2021 & 2031

Figure 19: Global Insulin Pen Market Y-o-Y Growth (%) By Region, 2021-2031

Figure 20: Global Insulin Pen Treatment Market Attractiveness Analysis, By Region

Figure 21: North America Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 22: North America Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 23: North America Insulin Pen  Market Share, By Product Type (2021)

Figure 24: North America Insulin Pen Market Share, By Distribution Channel (2021)

Figure 25: North America Insulin Pen Market Share, By Indication  (2021)

Figure 26: North America Insulin Pen Market Share, By Country (2021)

Figure 27: North America Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 28: North America Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 29: North America Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 30: North America Insulin Pen Market Attractiveness Analysis, By Country

Figure 31: Latin America America Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 32: Latin America Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 33: Latin America Insulin Pen  Market Share, By Product Type (2021)

Figure 34: Latin America Insulin Pen Market Share, By Distribution Channel (2021)

Figure 35: Latin America Insulin Pen Market Share, By Indication  (2021)

Figure 36: Latin America Insulin Pen Market Share, By Country (2021)

Figure 37: Latin America Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 38: Latin America Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 39: Latin America Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 40: Latin America Insulin Pen Market Attractiveness Analysis, By Country

Figure 41: Europe Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 42: Europe Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 43: Europe Insulin Pen Market Share, By Product Type (2021)

Figure 44: Europe Insulin Pen Market Share, By Distribution Channel (2021)

Figure 45: Europe Insulin Pen Market Share, By Indication  (2021)

Figure 46: Europe Insulin Pen Market Share, By Country (2021)

Figure 47: Europe Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 48: Europe Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 49: Europe Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 50: Europe Insulin Pen Market Attractiveness Analysis, By Country

Figure 51: South Asia Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 52: South Asia Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 53: South Asia Insulin Pen Market Share, By Product Type (2021)

Figure 54: South Asia Insulin Pen Market Share, By Distribution Channel (2021)

Figure 55: South Asia Insulin Pen Market Share, By Indication  (2021)

Figure 56: South Asia Insulin Pen Market Share, By Country (2021)

Figure 57: South Asia Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 58: South Asia Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 59: South Asia Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 60: South Asia Insulin Pen Market Attractiveness Analysis, By Country

Figure 61: East Asia Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 62: East Asia Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 63: East Asia Insulin Pen Market Share, By Product Type (2021)

Figure 64: East Asia Insulin Pen Market Share, By Distribution Channel (2021)

Figure 65: East Asia Insulin Pen Market Share, By Indication  (2021)

Figure 66: East Asia Insulin Pen Market Share, By Country (2021)

Figure 67: East Asia Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 68: East Asia Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 69: East Asia Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 70: East Asia Insulin Pen Market Attractiveness Analysis, By Country

Figure 71: Oceania Asia Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 72: Oceania Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 73: Oceania Insulin Pen Market Share, By Product Type (2021)

Figure 74: Oceania Insulin Pen Market Share, By Distribution Channel (2021)

Figure 75: Oceania Insulin Pen Market Share, By Indication  (2021)

Figure 76: Oceania Insulin Pen Market Share, By Country (2021)

Figure 77: Oceania Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 78: Oceania Asia Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 79: Oceania Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 80: Oceania Insulin Pen Market Attractiveness Analysis, By Country

Figure 81: MEA Insulin Pen Market Value (US$ Mn) Analysis, 2016–2020

Figure 82: MEA Insulin Pen Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 83: MEA Insulin Pen Market Share, By Product Type (2021)

Figure 84: MEA Insulin Pen Market Share, By Distribution Channel (2021)

Figure 85: MEA Insulin Pen Market Share, By Indication  (2021)

Figure 86: MEA Insulin Pen Market Share, By Country (2021)

Figure 87: MEA Insulin Pen Market Attractiveness Analysis, By Product Type 

Figure 88: MEA Insulin Pen Market Attractiveness Analysis, By Indication 

Figure 89: MEA Insulin Delivery Pen Market Attractiveness Analysis, By Distribution Channel

Figure 90: MEA Insulin Pen Market Attractiveness Analysis, By Country

Figure 91: U.S. Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 92: U.S. Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 93: U.S. Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 94: Global Vs. U.S. Growth Comparison

Figure 95: Canada Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 96: Canada Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 97: Canada Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 98: Global Vs. Canada Growth Comparison

Figure 99: Brazil Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 100: Brazil Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 101: Brazil Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 102: Global Vs. Brazil Growth Comparison

Figure 103: Mexico Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 104: Mexico Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 105: Mexico Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 106: Global Vs. Mexico Growth Comparison

Figure 107: Argentina Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 108: Argentina Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 109: Argentina Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 110: Global Vs. Argentina Growth Comparison

Figure 111: Germany Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 112: Germany Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 113: Germany Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 114: Global Vs. Germany Growth Comparison

Figure 115: U.K. Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 116: U.K. Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 117: U.K. Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 118: Global Vs. U.K. Growth Comparison

Figure 119: France Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 120: France Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 121: France Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 122: Global Vs. France Growth Comparison

Figure 123: Italy Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 124: Italy Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 125: Italy Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 126: Global Vs. Italy Growth Comparison

Figure 127: Spain Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 128: Spain Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 129: Spain Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 130: Global Vs. Spain Growth Comparison

Figure 131: BENELUX Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 132: BENELUX Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 133: BENELUX Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 134: Global Vs. BENELUX Growth Comparison

Figure 135: Russia Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 136: Russia Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 137: Russia Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 138: Global Vs. Russia Growth Comparison

Figure 139: India Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 140: India Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 141: India Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 142: Global Vs. India Growth Comparison

Figure 143: Thailand Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 144: Thailand Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 145: Thailand Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 146: Global Vs. Thailand Growth Comparison

Figure 147: Indonesia Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 148: Indonesia Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 149: Indonesia Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 150: Global Vs. Indonesia Growth Comparison

Figure 151: Malaysia Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 152: Malaysia Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 153: Malaysia Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 154: Global Vs. Malaysia Growth Comparison

Figure 155: China Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 156: China Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 157: China Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 158: Global Vs. China Growth Comparison

Figure 159: Japan Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 160: Japan Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 161: Japan Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 162: Global Vs. Japan Growth Comparison

Figure 163: South Korea Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 164: South Korea Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 165: South Korea Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 166: Global Vs. South Korea Growth Comparison

Figure 167: Australia Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 168: Australia Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 169: Australia Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 170: Global Vs. Australia Growth Comparison

Figure 171: New Zealand Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 172: New Zealand Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 173: New Zealand Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 174: Global Vs. New Zealand Growth Comparison

Figure 175: GCC Countries Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 176: GCC Countries Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 177: GCC Countries Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 178: Global Vs. GCC Countries Growth Comparison

Figure 179: South Africa Countries Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 180: South Africa Countries Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 181: South Africa Countries Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 182: Global Vs. South Africa Countries Growth Comparison

Figure 183: South Africa Countries Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 184: South Africa Countries Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 185: South Africa Countries Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 186: Global Vs. South Africa Countries Growth Comparison

Figure 187: North Africa Countries Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 188: North Africa Countries Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 189: North Africa Countries Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 190: Global Vs. North Africa Countries Growth Comparison

Figure 191: Turkey Countries Insulin Pen Market Analysis (%) By Product Type, 2021 & 2031

Figure 192: Turkey Countries Insulin Pen Market Analysis (%) By Indication Type, 2021 & 2031

Figure 193: Turkey Countries Insulin Pen Market Analysis (%) By Distribution Channel, 2021 & 2031

Figure 194: Global Vs. Turkey Countries Growth Comparison 

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate